OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Writers, readers, and erasers RNA modifications and drug resistance in cancer
Di Chen, Xinyu Gu, Yeltai Nurzat, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 14

Showing 14 citing articles:

Pharmacology of Epitranscriptomic Modifications: Decoding the Therapeutic Potential of RNA Modifications in Drug Resistance
Abdullah Alkhammash
European Journal of Pharmacology (2025) Vol. 994, pp. 177397-177397
Closed Access

RNA Modification in Metabolism
Yadi Liu, Zhongyan Sun, Dingkun Gui, et al.
MedComm (2025) Vol. 6, Iss. 3
Open Access

Circular RNA in liver cancer research: biogenesis, functions, and roles
Jia‐Yi Wang, Congcong Zhang, Yinghui Zhang, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access

PCIF1 drives oesophageal squamous cell carcinoma progression via m6Am‐mediated suppression of MTF2 translation
Kang Li, Yi Yang, Rongsong Ling, et al.
Clinical and Translational Medicine (2025) Vol. 15, Iss. 4
Open Access

5-Methylcytosine RNA modification and its roles in cancer and cancer chemotherapy resistance
Li Fang, Tingting Liu, Yi Dong, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access

Dynamic rRNA modifications as a source of ribosome heterogeneity
Ivan Milenkovic, Eva Maria Novoa
Trends in Cell Biology (2024)
Closed Access | Times Cited: 2

INTERPLAY BETWEEN EPIGENETICS, SENESCENCE AND CELLULAR REDOX METABOLISM IN CANCER AND ITS THERAPEUTIC IMPLICATIONS
Geoffrey Balamurli, Angeline Qiu Xia Liew, Wee‐Wei Tee, et al.
Redox Biology (2024) Vol. 78, pp. 103441-103441
Open Access | Times Cited: 1

5-methylcytosine methylation of MALAT1 promotes resistance to sorafenib in hepatocellular carcinoma through ELAVL1/SLC7A11-mediated ferroptosis
Chuan-Jian Shi, Fengxiang Pang, Yuhe Lei, et al.
Drug Resistance Updates (2024) Vol. 78, pp. 101181-101181
Open Access | Times Cited: 1

Page 1

Scroll to top